42.45 USD
-0.6 (-1.39%)
42.8054 USD
+0.36 (+0.84%)
VCYT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 528 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make VCYT a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- In the past year VCYT was profitable.
- In the past year VCYT had a positive cash flow from operations.
- VCYT had negative earnings in 4 of the past 5 years.
- In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- VCYT has a Return On Assets of 2.21%. This is amongst the best in the industry. VCYT outperforms 89.20% of its industry peers.
- VCYT has a better Return On Equity (2.40%) than 90.15% of its industry peers.
- VCYT has a better Return On Invested Capital (2.96%) than 89.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROIC | 2.96% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of VCYT (6.10%) is better than 89.96% of its industry peers.
- VCYT has a better Operating Margin (9.81%) than 91.48% of its industry peers.
- VCYT has a Gross Margin of 68.53%. This is amongst the best in the industry. VCYT outperforms 81.06% of its industry peers.
- VCYT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
- The number of shares outstanding for VCYT has been increased compared to 1 year ago.
- VCYT has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- VCYT has an Altman-Z score of 18.94. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
- VCYT's Altman-Z score of 18.94 is amongst the best of the industry. VCYT outperforms 88.07% of its industry peers.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.94 |
ROIC/WACC0.34
WACC8.82%
2.3 Liquidity
- A Current Ratio of 6.24 indicates that VCYT has no problem at all paying its short term obligations.
- VCYT's Current ratio of 6.24 is fine compared to the rest of the industry. VCYT outperforms 64.02% of its industry peers.
- VCYT has a Quick Ratio of 5.96. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT's Quick ratio of 5.96 is fine compared to the rest of the industry. VCYT outperforms 63.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 353.33% over the past year.
- The Revenue has grown by 16.41% in the past year. This is quite good.
- VCYT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.93% yearly.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- The Earnings Per Share is expected to grow by 51.21% on average over the next years. This is a very strong growth
- Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 11.52% on average per year.
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 111.71, which means the current valuation is very expensive for VCYT.
- Compared to the rest of the industry, the Price/Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 89.58% of the companies listed in the same industry.
- VCYT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.33.
- The Price/Forward Earnings ratio is 40.35, which means the current valuation is very expensive for VCYT.
- VCYT's Price/Forward Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 91.48% of the companies in the same industry.
- VCYT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.71 | ||
| Fwd PE | 40.35 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.67% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 93.37% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.15 | ||
| EV/EBITDA | 42.32 |
4.3 Compensation for Growth
- VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VCYT has a very decent profitability rating, which may justify a higher PE ratio.
- VCYT's earnings are expected to grow with 59.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y87.27%
EPS Next 3Y59.79%
5. Dividend
5.1 Amount
- No dividends for VCYT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
42.45
-0.6 (-1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners114.83%
Inst Owner Change-0.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap3.36B
Revenue(TTM)495.14M
Net Income(TTM)30.18M
Analysts82.11
Price Target49.33 (16.21%)
Short Float %6.68%
Short Ratio5.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0%
PT rev (3m)17.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)1.3%
EPS NY rev (3m)40.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.71 | ||
| Fwd PE | 40.35 | ||
| P/S | 6.78 | ||
| P/FCF | 34.15 | ||
| P/OCF | 31.07 | ||
| P/B | 2.67 | ||
| P/tB | 8.41 | ||
| EV/EBITDA | 42.32 |
EPS(TTM)0.38
EY0.9%
EPS(NY)1.05
Fwd EY2.48%
FCF(TTM)1.24
FCFY2.93%
OCF(TTM)1.37
OCFY3.22%
SpS6.26
BVpS15.91
TBVpS5.05
PEG (NY)1.45
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROCE | 3.75% | ||
| ROIC | 2.96% | ||
| ROICexc | 4.13% | ||
| ROICexgc | 54.36% | ||
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% | ||
| FCFM | 19.84% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.32% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.06% | ||
| Profit Quality | 325.55% | ||
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 18.94 |
F-Score8
WACC8.82%
ROIC/WACC0.34
Cap/Depr(3y)39.23%
Cap/Depr(5y)36.18%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
EBIT growth 1Y433.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y48.27%
FCF growth 1Y237.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.1%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 111.71 and the Price/Book (PB) ratio is 2.67.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.